- Home
- PLUR vs OPAD Comparison
PLUR vs OPAD Comparison
Compare PLUR & OPAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLUR
- OPAD
- Stock Information
- Founded
- PLUR 2001
- OPAD 2015
- Country
- PLUR Israel
- OPAD United States
- Employees
- PLUR N/A
- OPAD N/A
- Industry
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- OPAD Real Estate
- Sector
- PLUR Health Care
- OPAD Finance
- Exchange
- PLUR Nasdaq
- OPAD Nasdaq
- Market Cap
- PLUR 37.6M
- OPAD 43.7M
- IPO Year
- PLUR N/A
- OPAD N/A
- Fundamental
- Price
- PLUR $4.48
- OPAD $3.06
- Analyst Decision
- PLUR Strong Buy
- OPAD Hold
- Analyst Count
- PLUR 1
- OPAD 5
- Target Price
- PLUR $12.00
- OPAD $2.41
- AVG Volume (30 Days)
- PLUR 9.3K
- OPAD 6.7M
- Earning Date
- PLUR 11-11-2025
- OPAD 11-03-2025
- Dividend Yield
- PLUR N/A
- OPAD N/A
- EPS Growth
- PLUR N/A
- OPAD N/A
- EPS
- PLUR N/A
- OPAD N/A
- Revenue
- PLUR $1,336,000.00
- OPAD $703,352,000.00
- Revenue This Year
- PLUR $246.11
- OPAD N/A
- Revenue Next Year
- PLUR $169.62
- OPAD $31.90
- P/E Ratio
- PLUR N/A
- OPAD N/A
- Revenue Growth
- PLUR 309.82
- OPAD N/A
- 52 Week Low
- PLUR $3.33
- OPAD $0.91
- 52 Week High
- PLUR $7.13
- OPAD $6.35
- Technical
- Relative Strength Index (RSI)
- PLUR 46.99
- OPAD 39.63
- Support Level
- PLUR $4.08
- OPAD $3.82
- Resistance Level
- PLUR $4.50
- OPAD $4.27
- Average True Range (ATR)
- PLUR 0.22
- OPAD 0.58
- MACD
- PLUR -0.02
- OPAD -0.21
- Stochastic Oscillator
- PLUR 65.05
- OPAD 2.14
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
About OPAD Offerpad Solutions Inc.
Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services including mortgage, listing, renovation and buyer representation services.